Efficacy of anlotinib in advanced soft tissue sarcoma by age, gender, and ECOG performance status.

被引：0
|
作者：
Fang, Zhiwei
Yao, Yang
Cai, Jianqiang
Chi, Yihebali
Wang, Shusen
Huang, Gang
Cai, Qiqing
Shang, Guanning
Wang, Guowen
Qu, Guofan
Wu, Qiong
Jiang, Yu
Song, Jianmin
Chen, Jing
Cai, Zhengdong
Zhu, Xia
Bai, Chunmei
Lu, Yongkui
Yu, Zhihua
Shen, Jingnan
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai, Peoples R China
[3] Canc Hosp, Dept Abdominal Surg, CAMS, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[6] Hunan Canc Hosp, Changsha, Peoples R China
[7] Henan Canc Hosp, Zhengzhou, Peoples R China
[8] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[9] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[10] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
[11] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[12] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[13] Gansu Prov Canc Hosp, Lanzhou, Peoples R China
[14] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[15] Shanghai Jiao Tong Univ, Peoples Hosp 1, Shanghai, Peoples R China
[16] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China
[17] Peking Union Med Coll Hosp, Beijing, Peoples R China
[18] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
[19] Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China
[20] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23562
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
    Inagaki, C.
    Shimoi, T.
    Okuma, H. S.
    Kawachi, A.
    Shimomura, A.
    Noguchi, E.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcoma
    Le Cesne, Axel
    Martin-Broto, Javier
    Grignani, Giovanni
    FUTURE ONCOLOGY, 2022, 18 (30S) : 5 - 11
  • [43] Efficacy of trabectedin for advanced soft tissue sarcoma (ASTS): A retrospective single center analysis
    Martinez-Trufero, Javier
    Pajares, Isabel
    Hernandez Garcia, Alba
    Cebollero, Ana
    Calera, Lourdes
    Anton, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
    Liu, Zhiyong
    Yao, Weitao
    Zhao, Yao
    Liu, Oufei
    Zhang, Peng
    Ge, Hong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1009 - 1016
  • [45] Efficacy and safety of anlotinib plus TQB2450 in patients with advanced soft tissue sarcoma: A multicenter, single armed, phase 1b trial.
    Liu, Jiayong
    Fan, Zhengfu
    Guo, Wei
    Gao, Tian
    Li, Shu
    Xu, Jie
    Bai, Chujie
    Xue, Ruifeng
    Zhang, Lu
    Xie, Lu
    Tan, Zhichao
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] A retrospective study of anlotinib combined with adriamycin and ifosfamide in unresectable soft tissue sarcoma.
    Long, Zuoyao
    Lu, Yajie
    Li, Minghui
    Chen, Guojing
    Li, Jing
    Fu, Zhanli
    Akbar, Yunus
    Zhang, Hong-Mei
    Wang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Anlotinib treatment in elderly patients with unresectable or metastatic soft tissue sarcoma: a retrospective study
    Zhang, Xin-Yao
    Liu, Jie
    Deng, Yao-Tiao
    Jiang, Yu
    ANTI-CANCER DRUGS, 2022, 33 (01) : E519 - E524
  • [48] Symptom Prevalence in Advanced Cancer: Age, Gender, and Performance Status Interactions
    Kirkova, Jordanka
    Rybicki, Lisa
    Walsh, Declan
    Aktas, Aynur
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2012, 29 (02): : 139 - 145
  • [49] Association of sex, age and ECOG performance status with cancer immunotherapy efficacy in randomized controlled trials.
    Yang, Fang
    Wang, Yucai
    Nowakowski, Grzegorz S.
    Wang, Michael
    Chintakuntlawar, Ashish V.
    Halfdanarson, Thorvardur Ragnar
    Pagliaro, Lance C.
    Wei, Jia
    Liu, Baorui
    Molina, Julian R.
    Markovic, Svetomir
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
    Le Cesne, Axel
    Bauer, Sebastian
    Demetri, George D.
    Han, Guangyang
    Dezzani, Luca
    Ahmad, Qasim
    Blay, Jean-Yves
    Judson, Ian
    Schoeffski, Patrick
    Aglietta, Massimo
    Hohenberger, Peter
    Gelderblom, Hans
    BMC CANCER, 2019, 19 (01)
12345